Montalban X - Search Results

1

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group. Comi G, et al. Among authors: montalban x. Mult Scler. 2010 Feb;16(2):197-207. doi: 10.1177/1352458509357065. Epub 2009 Dec 22. Mult Scler. 2010. PMID: 20028707 Clinical Trial.

2

Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial.

Fernández O, Antiquëdad A, Arbizu T, Capdevíla A, de Castro P, Correa de Sa JC, García-Merino JA, Izquierdo G, Magalhaes A, Montalbán X, et al. Fernández O, et al. Among authors: montalban x. Mult Scler. 1995;1 Suppl 1:S67-9. Mult Scler. 1995. PMID: 9345404 Clinical Trial.

3

Durán I, Martínez-Cáceres EM, Brieva L, Tintoré M, Montalban X. Durán I, et al. Among authors: montalban x. Mult Scler. 2001 Jun;7(3):151-6. doi: 10.1177/135245850100700303. Mult Scler. 2001. PMID: 11475437

4

Two-year follow-up study of primary and transitional progressive multiple sclerosis.

Ingle GT, Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Thompson AJ. Ingle GT, et al. Among authors: montalban x. Mult Scler. 2002 Apr;8(2):108-14. doi: 10.1191/1352458502ms778oa. Mult Scler. 2002. PMID: 11990866

5

Can the Expanded Disability Status Scale be assessed by telephone?

Lechner-Scott J, Kappos L, Hofman M, Polman CH, Ronner H, Montalban X, Tintore M, Frontoni M, Buttinelli C, Amato MP, Bartolozzi ML, Versavel M, Dahlke F, Kapp JF, Gibberd R. Lechner-Scott J, et al. Among authors: montalban x. Mult Scler. 2003 Mar;9(2):154-9. doi: 10.1191/1352458503ms884oa. Mult Scler. 2003. PMID: 12708811

6

Unconventional therapy in multiple sclerosis.

Sastre-Garriga J, Munteis E, Río J, Pericot I, Tintoré M, Montalban X. Sastre-Garriga J, et al. Among authors: montalban x. Mult Scler. 2003 Jun;9(3):320-2. doi: 10.1191/1352458503ms913sr. Mult Scler. 2003. PMID: 12814183

7

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.

Lampasona V, Rio J, Franciotta D, Furlan R, Avolio C, Fazio R, Lavolpe V, Vincent A, Comi G, Trojano M, Montalban X, Martino G. Lampasona V, et al. Among authors: montalban x. Eur Cytokine Netw. 2003 Jul-Sep;14(3):154-7. Eur Cytokine Netw. 2003. PMID: 14656689 Free article.

8

Towards a european network for multiple sclerosis trials (ENMST).

Kappos L, Polman C, Thompson AJ, Duda P, Clanet M, Comi G, Hartung HP, Montalban X. Kappos L, et al. Among authors: montalban x. Mult Scler. 2003 Dec;9(6):627-9. doi: 10.1191/1352458503ms962xx. Mult Scler. 2003. PMID: 14664478

9

Decreased MMP-9 production in primary progressive multiple sclerosis patients.

Sastre-Garriga J, Comabella M, Brieva L, Rovira A, Tintoré M, Montalban X. Sastre-Garriga J, et al. Among authors: montalban x. Mult Scler. 2004 Aug;10(4):376-80. doi: 10.1191/1352458504ms1058oa. Mult Scler. 2004. PMID: 15327032

10

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

Nos C, Sastre-Garriga J, Borràs C, Río J, Tintoré M, Montalban X. Nos C, et al. Among authors: montalban x. Mult Scler. 2004 Aug;10(4):413-6. doi: 10.1191/1352458504ms1068oa. Mult Scler. 2004. PMID: 15327039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

786 results

Search Page